REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
24/05/2025
Voltar para busca
Dado oficial do USPTO
EVALAR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
51
Atualização mais recente
25/05/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5
Data de depósito
09/07/2014
Data de registro
24/05/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/03/2022
Última transação
25/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
RU-659332 Altai Territory, RU
Examinador
JOINER, KATINA
Unidade examinadora
L40
Descrição da marca
The mark consists of the term "EVALAR" in white inside a green stylized leaf design with a white swoop design beneath the letters "VALA" in the term "EVALAR".
Titulares e representantes
Titulares
Zakrytoe aktsionernoe obshchestvo "Evalar"
Representantes
Elise Tenen-Aoki TA IP Law, P.C. A Law Corporation
Classificação técnica
Classes Nice
Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Greases for cosmetic purposes; cosmetic creams; hair lotions; lotions for cosmetic purposes; beauty masks; oils for cosmetic purposes; essential oils; cleansing milk for toilet purposes; cosmetic preparations for baths; non-medicated mouthwash; cosmetic preparations for slimming purposes; sunscreen preparations; potpourri; cosmetic sun-tanning preparations; cosmetic preparations for skin care; cosmetics; shampoos; extracts of flowers sold as components of cosmetics; ethereal essences and extracts of herbs for cosmetic purposes
Classe 5
Analgesics; antibiotics; balms for medical purposes; dietary fiber for use as an ingredient in the manufacture of dietary supplements; mineral food supplements; nutritional supplements; medicinal roots; collodion for pharmaceutical purposes; licorice for pharmaceutical purposes; candy for medical purposes; medicines for alleviating constipation; liniments; antibiotic ointments; medicinal oils for the treatment of skin diseasesfor use as medicated skin care preparationsas medicated hair care preparations; drugs for medical purposesantimicrobial preparations for inhibiting microbiological decomposition in foodbeverages and pharmaceuticals; medicines for human purposespharmaceutical preparations for treating of disorders of gastrointestinal system; medicinal drinks; flour for pharmaceutical purposes; mint for pharmaceutical purposes; medicinal infusions for treating of disorders of the nervousimmunecardiovascular and metabolic systemsthe gastro-intestinal systemthe respiratory and genito-urinary systemsmusculo-skeletal and inflammatory disordersfor use in dermatologyophthalmology; decoctions for pharmaceutical purposes for treating of disorders of the nervousimmunecardio-vascular and metabolic systemsthe gastro-intestinal systemthe respiratory and genito-urinary systemsmusculo-skeletal and inflammatory disordersfor use in dermatologyophthalmology; food for babies; vitamin preparations; hemorrhoid treatment preparations; eye-washes; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; medicinal hair growth preparations; preparations of trace elements for human use for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardlo-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genito-urinary systemthe gastro-intestinal systemfor use as dietetic supplementsnutritional additives for medical purposes; pharmaceutical preparations for the treatment of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe rnusculo-skeletal systemthe genito-urinary systemthe gastro-intestinal systemfor the treatment of inflammatory disordersfor use in dermatology; enzyme preparations for medical purposes for the treatment of disorders of gastro-intestinal system; chemico-pharmaceutical preparations for the treatment of disorders of the nervous systemthe immune systemthe vascular and metabolic systemsthe respiratory and genito-urinary systemsmusculoskeletal and inflammatory disorders or for use in dermatologyophthalmologyfor gastro-enterologyfor the prevention and treatment of ocular disordersfor use as anti-infectiveantiparasiticantibioticanti-bacterialantiviral and antifungal; chemical preparations for pharmaceutical or medical purposesfor the treatment of disorders of the nervous systemthe immune systemthe vascular and metabolic systemsthe respiratory and genito-urinary systemsmusculoskeletal and inflammatory disorders or for use in dermatologyophthalmologyfor gastro-enterologyfor the prevention and treatment of ocular disordersfor use as anti-infectiveantiparasiticantibioticanti-bacterialantiviral and antifungal; collyrium; dietetic foodscrackers adapted for medical use; by-products of the processing of cereals for medical purposes; propolis for medicinal or therapeutic purposes; asthmatic tea; linseed dietary supplements ; syrups for pharmaceutical purposes for the treatment of cough; soporifics; bath salts for medical purposes; malt for pharmaceutical purposes; medicinal alcohol; appetite suppressants for medical purposes; medical preparations for slimming purposes; mouthwashes for medical purposes; febrifuges; purgatives; antiparasitic preparations; sedatives; tranquilizers; laxatives; digestives for pharmaceutical purposes; appetite suppressant pills; slimming pills; medicinal herbs; charcoal for pharmaceutical purposes; enzymes for medical purposes; medicinal tea; herbal teas for medicinal purposes; plant and herb extracts for medicinal purposes; elixirspharmaceutical preparations for the treating of disorders of the nervousimmunecardio-vascular and metabolic systemsthe gastro-intestinal systemthe respiratory and genito-urinary systemsmusculo-skeletal and inflammatory disordersfor use in dermatology
Publicações
Histórico de despachos e eventos da marca no USPTO.
51 publicações encontradas
RNWL
INTERNATIONAL REGISTRATION RENEWED
19/12/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
31/01/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
07/12/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
07/12/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/11/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
11/03/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
11/03/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/03/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
12/08/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
14/06/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/06/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
14/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/06/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
14/06/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/04/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
25/08/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
25/08/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/08/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
24/05/2016
PUBO
PUBLISHED FOR OPPOSITION
08/03/2016
GPNX
NOTIFICATION PROCESSED BY IB
04/03/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/02/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/02/2016
NPUB
NOTICE OF PUBLICATION
17/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2016
ACEC
AMENDMENT FROM APPLICANT ENTERED
30/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2016
PAPER RECEIVED
27/01/2016
CNRT
NON-FINAL ACTION MAILED
03/12/2015
CNRT
NON-FINAL ACTION WRITTEN
02/12/2015
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
16/11/2015
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
28/10/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/10/2015
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/10/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2015
ALIE
ASSIGNED TO LIE
25/09/2015
PAPER RECEIVED
10/09/2015
RFNT
REFUSAL PROCESSED BY IB
07/06/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/05/2015
RFRR
REFUSAL PROCESSED BY MPU
21/05/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/05/2015
CNRT
NON-FINAL ACTION WRITTEN
20/05/2015
MAFR
APPLICATION FILING RECEIPT MAILED
19/05/2015
DOCK
ASSIGNED TO EXAMINER
16/05/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/05/2015
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
15/05/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/05/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EVALAR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.